Effect of Stem Cell Factor, Interleukin–6, Nitric Oxide and Transforming Growth Factor–β on the Osteoclast Differentiation Induced by 1α,25–(OH)2D3in Primary Murine Bone Marrow Cultures
Open Access
- 1 May 1998
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 82 (5) , 223-229
- https://doi.org/10.1111/j.1600-0773.1998.tb01429.x
Abstract
Osteotropic hormones and cytokines are involved in the differentiation of osteoclast progenitors from haematopoietic stem cells to multinucleated osteoclasts which mediate bone resorption. Stem cell factor, interleukin–6, nitric oxide, and transforming growth factor–β are implicated in the regulation of bone resorption by osteoclast. We test whether stem cell factor, interleukin–6, nitric oxide, and transforming growth factor–β affect the generation of osteoclast–like multinucleated cells induced by 1α,25–(OH)2D3. 1α,25–(OH)2D3increases the generation of osteoclast–like cells retaining osteoclast characteristics including multinuclearity and positive staining for tartrate–resistant acid phosphatase. Combined treatment of stem cell factor with interleukin–6 synergistically potentiates the ability of 1α,25–(OH)2D3to generate tartrate–resistant acid phosphatase–positive multinucleated cells. However, either stem cell factor or interleukin–6 alone does not induce the generation of tartrate–resistant acid phosphatase–positive multinucleated cells. Transforming growth factor–β produces a biphasic effect on osteoclast generation induced by 1α,25–(OH)2D3. Transforming growth factor–β stimulates osteoclast generation at low concentration (0.1 ng/ml) whereas it suppresses the formation of osteoclast–like cell at higher concentration (1 ng/ml). Sodium nitroprusside, a donor of nitric oxide, almost completely inhibits the generation of 1α,25–(OH)2D3–induced osteoclast at high concentration (100 μM), but it significantly enhances the osteoclast generation at low concentrations (3 μM). These results suggest that stem cell factor, interleukin–6, transforming growth factor–β, and nitric oxide interact with 1α,25–(OH)2D3to modulate the differentiation of hematopoietic precursors toward committed osteoclast precursors.Keywords
This publication has 40 references indexed in Scilit:
- Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandinsBone, 1996
- Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.Journal of Clinical Investigation, 1994
- Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in paget's diseaseJournal of Bone and Mineral Research, 1994
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Embryonic expression of a haematopoietic growth factor encoded by the SI locus and the ligand for c-kitNature, 1990
- In vivo effects of human recombinant transforming growth factor β on bone turnover in normal miceJournal of Bone and Mineral Research, 1990
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989
- Interleukin-6 in synovial fluid from patients with arthritisClinical Immunology and Immunopathology, 1989
- Activation of the bone-derived latent TGF beta complex by isolated osteoclastsBiochemical and Biophysical Research Communications, 1989
- Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gammaJournal of Bone and Mineral Research, 1986